Jump to content

Stephen Friend

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Citation bot (talk | contribs) at 01:50, 6 May 2020 (Alter: journal. Add: bibcode. | You can use this bot yourself. Report bugs here. | Activated by RayScript | via #UCB_toolbar). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Stephen Friend at NightScience 2013 in Paris

Stephen H. Friend is the president, co-founder and director of Sage Bionetworks.[1][2][3]

Formerly Senior Vice-President at Merck & Co. Friend co-founded Rosetta Inpharmatics with Leland H. Hartwell and Leroy Hood in 1996.[4] Much of his research has focused on cancer.[5]

Friend has also held faculty positions at Harvard Medical School and at Massachusetts General Hospital. He received his Bachelor of Arts in philosophy, his Ph.D. in biochemistry and his M.D. from Indiana University.[2]

Recognition

Friend is named an Ashoka Fellow by Ashoka: Innovators for the Public in 2011.[6]

Selected bibliography

  • Bartz, S. R.; Zhang, Z; Burchard, J; Imakura, M; Martin, M; Palmieri, A; Needham, R; Guo, J; Gordon, M; Chung, N; Warrener, P; Jackson, A. L.; Carleton, M; Oatley, M; Locco, L; Santini, F; Smith, T; Kunapuli, P; Ferrer, M; Strulovici, B; Friend, S. H.; Linsley, P. S. (2006). "Small interfering RNA screens reveal enhanced cisplatin cytotoxicity in tumor cells having both BRCA network and TP53 disruptions". Molecular and Cellular Biology. 26 (24): 9377–86. doi:10.1128/MCB.01229-06. PMC 1698535. PMID 17000754.
  • Radich, J. P.; Dai, H; Mao, M; Oehler, V; Schelter, J; Druker, B; Sawyers, C; Shah, N; Stock, W; Willman, C. L.; Friend, S; Linsley, P. S. (2006). "Gene expression changes associated with progression and response in chronic myeloid leukemia". Proceedings of the National Academy of Sciences. 103 (8): 2794–9. Bibcode:2006PNAS..103.2794R. doi:10.1073/pnas.0510423103. PMC 1413797. PMID 16477019.
  • Dai, H; Van't Veer, L; Lamb, J; He, Y. D.; Mao, M; Fine, B. M.; Bernards, R; Van De Vijver, M; Deutsch, P; Sachs, A; Stoughton, R; Friend, S (2005). "A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients". Cancer Research. 65 (10): 4059–66. doi:10.1158/0008-5472.CAN-04-3953. PMID 15899795.
  • Lampe, J. W.; Stepaniants, S. B.; Mao, M; Radich, J. P.; Dai, H; Linsley, P. S.; Friend, S. H.; Potter, J. D. (2004). "Signatures of environmental exposures using peripheral leukocyte gene expression: Tobacco smoke". Cancer Epidemiology, Biomarkers & Prevention. 13 (3): 445–53. PMID 15006922.
  • Van 't Veer, L. J.; Dai, H; Van De Vijver, M. J.; He, Y. D.; Hart, A. A.; Bernards, R; Friend, S. H. (2003). "Expression profiling predicts outcome in breast cancer". Breast Cancer Research. 5 (1): 57–8. doi:10.1186/bcr562. PMC 154139. PMID 12559048.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  • Van De Vijver, M. J.; He, Y. D.; Van't Veer, L. J.; Dai, H; Hart, A. A.; Voskuil, D. W.; Schreiber, G. J.; Peterse, J. L.; Roberts, C; Marton, M. J.; Parrish, M; Atsma, D; Witteveen, A; Glas, A; Delahaye, L; Van Der Velde, T; Bartelink, H; Rodenhuis, S; Rutgers, E. T.; Friend, S. H.; Bernards, R (2002). "A gene-expression signature as a predictor of survival in breast cancer". New England Journal of Medicine. 347 (25): 1999–2009. doi:10.1056/NEJMoa021967. PMID 12490681.
  • Lamb, J. R.; Zhang, C; Xie, T; Wang, K; Zhang, B; Hao, K; Chudin, E; Fraser, H. B.; Millstein, J; Ferguson, M; Suver, C; Ivanovska, I; Scott, M; Philippar, U; Bansal, D; Zhang, Z; Burchard, J; Smith, R; Greenawalt, D; Cleary, M; Derry, J; Loboda, A; Watters, J; Poon, R. T.; Fan, S. T.; Yeung, C; Lee, N. P.; Guinney, J; Molony, C; et al. (2011). "Predictive genes in adjacent normal tissue are preferentially altered by sCNV during tumorigenesis in liver cancer and may rate limiting". PLOS ONE. 6 (7): e20090. Bibcode:2011PLoSO...620090L. doi:10.1371/journal.pone.0020090. PMC 3130029. PMID 21750698.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  • Mihich, E; Feunteun, J; Friend, S (2002). "Thirteenth annual pezcoller symposium: Focusing analytical tools on complexity in cancer". Cancer Research. 62 (13): 3883–7. PMID 12097304.

References

  1. ^ Kaiser, J. (2012). "The Visionary". Science. 335 (6069): 651–3. doi:10.1126/science.335.6069.651. PMID 22323794.
  2. ^ a b "Sage Bionetworks Seattle | Directors". Archived from the original on 2012-02-11. Retrieved 2012-02-11.
  3. ^ "Stephen Friend". Nature Reviews Drug Discovery. 7 (2): 114. 2008. doi:10.1038/nrd2509.
  4. ^ Nelson, Bryn; Schadt, E (2009). "Something wiki this way comes". Nature. 458 (7234): 13. doi:10.1038/458013a. PMID 19262635.
  5. ^ Kaiser, J. (2012). "The Visionary". Science. 335 (6069): 651–3. doi:10.1126/science.335.6069.651. PMID 22323794.
  6. ^ http://sagebase.org/info/NewsInfoDownloads/SageAshokaRelease6APR2011.pdf[dead link‍]
Retrieved from "https://en.wikipedia.org/w/index.php?title=Stephen_Friend&oldid=955117842"